TOLDBODGADE 33, 1253 COPENHAGEN K, G7
Reports on Form 6-K for May 2026
Capital Increase as a Result of Employee Warrant Exercise
Standard Form for Notification of Major Holdings
Announces Financial Results for the First Quarter of 2026
Share Capital Reduction Company Announcement
Reports on Form 6-K for April 2026
Shareholder Notification of Major Holdings
Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026
Annual and Transition Report of Foreign Private Issuers
Registration Statement for Securities to be Offered to Employees
Tender Offer Statement by Third Party
Tender Offer Statement by Issuer
Effectiveness Notice
No filings found
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Schedule 13D - Ownership Report
Amended Tender Offer Statement by Third Party
Registration Statement for Depositary Shares
Registration Statement for Additional Securities of Certain Foreign Private Issuers, Filed Pursuant to Rule 462(b)
Registration Statement for Depositary Shares, Issued upon Effectiveness